Perhaps this is not the forum in which to do this, but we have been talking about risk assessment processes. I think for PBDEs, for example, which have been evaluated by some kind of risk assessment process, now that they're found in the breast tissue of women in Canada at rates higher than are seen in Sweden, it's hardly a ringing endorsement of the risk assessment process. Presumably that compound went through a risk assessment process, and now we're finding high levels in women in Canada. I think that whole risk assessment process has to be put into question.
Somebody mentioned the precautionary approach. In fact, there is a whole scholarly and academic and policy arena where this is being discussed, where they are looking at the precautionary approach or precautionary-based assessment versus the risk assessment process. It has very different premises and different methodologies. Perhaps we need to start looking at that and perhaps invite some kind of forum or conference on evaluating the implications of using a precautionary approach to these chemicals versus the risk-based assessment. That hasn't been done in Canada. I know it's been done in the U.S.